Interleukin Enhancer Binding Factor 2, 45kDa (ILF2) (N-Term) Peptide
ILF2
Reactivity: Human, Mouse
Host: Synthetic
BP, WB
Catalog No. ABIN2185108
Quick Overview for Interleukin Enhancer Binding Factor 2, 45kDa (ILF2) (N-Term) Peptide (ABIN2185108)
Target
ILF2
(Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
Origin
Human, Mouse
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequence
- KRNQDLAPNS AEQASILSLV TKINNVIDNL IVAPGTFEVQ IEEVRQVGSY
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Ilf2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
-
Background
-
Ilf2 appears to function predominantly as a heterodimeric complex with ILF3. This complex may regulate transcription of the IL2 gene during T-cell activation. It can also promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA.
Alias Symbols: 6230405A16Rik, TEG-267, Tex261, Tex267
Protein Size: 390 -
Molecular Weight
- 42 kDa
-
Gene ID
- 67781
-
NCBI Accession
- NM_026374, NP_080650
-
UniProt
- Q9CXY6
Target
-
You are here:
